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 Tuberculosis (TB) is the most frequently diagnosed opportunistic infection 
(OI) and disease in people living with HIV/AIDS (PLWHA), world-wide. 
This study aimed at determining the incidence and predictors of tuberculosis 
among people living with HIV. A Six year retrospective follow up study was 
conducted among adult PLHIV. The Cox proportional hazards model was 
used to identify predictors. A total of 554 patients were followed and 
produced 1830.3 person year of observation. One hundred sixty one new TB 
cases occurred during the follow up period. The overall incidence density of 
TB was 8.79 per 100 person-year (PY). It was high (148.71/100 PY) in the 
first year of enrolment. The cumulative proportion of TB free survival was 
79% and 67% at the end of first and sixth years, respectively. Not having 
formal education(AHR=2.68, 95%CI: 1.41, 5.11 ), base line WHO clinical 
stage IV (AHR = 3.22, 95% CI=1.91-5.41), CD4 count <50 cell/ul  
(AHR=2.41, 95%CI=1.31, 4.42), Being bed redden (AHR= 2.89, 
95%CI=1.72, 3.78), past TB history (AHR=1.65, 95% CI = 1.06,2.39), 
substance use (AHR=1.46, 95% CI=1.03,2.06) and being on pre ART 
(AHR=1.62, 95%CI: 1.03-2.54 ) were independently predicted tuberculosis 
occurrence. Advanced WHO clinical stage, limited functional status, past TB 
history, addiction and low CD4 (<50cell/ul) count at enrollment were found 
to be the independent predictor of tuberculosis occurrence. Therefore early 
initiation of treatment and intensive follow up is important. 
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1. INTRODUCTION 
Human immunodeficiency virus (HIV) infection is the greatest risk factor for acquiring 
Mycobacterium tuberculosis infection and developing tuberculosis (TB) [1]. Tuberculosis is the most 
frequently diagnosed opportunistic infection (OI) and disease in people living with HIV/AIDS (PLWHA), 
world-wide [2]. Despite being preventable it is still a leading cause of morbidity and mortality in PLWHA. 
At least one in four deaths among PLWHA can be attributed to TB and many of these deaths occur in 
developing countries, like African countries [3]. HIV positive people with latent TB infection have a 10% 
annual and 50% lifetime risk of developing active TB disease, opposed to 10% of life time risk of HIV 
negative individuals [4]. As a result, TB becomes a major public health problem, particularly in area where 
HIV infection rates is higher [5]. Globally 1.2 million (12%) of 9.6 million people who developed TB 
(incidence) were HIV positive in 2014. Among these 74% HIV positive TB cases were in Africa. Even 
though the number of people dying from HIV associated TB in last decade decreases, it kills 25% (390,000) 
of all TB deaths and one third of the estimated 1.2 million deaths from HIV/AIDS [6]. According to World 
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Bank report, people who are latently infected with mycobacterium tuberculosis (about one third of 
inhabitants of Sub-Saharan Africa) are at greater risk of developing active TB, they are also immunologically 
weekend by concurrent HIV infection [7],[8]. 
Ethiopia is one of 22 World high burden countries of TB, ranking seventh and among top five in 
Africa [9]. According to WHO global TB report of 2015 the country had estimated 200,000 TB cases in 2014 
with an estimated incidence rate of 207 cases per 100,000 populations [6]. In recent years, great efforts have 
been made to integrate TB diagnosis and treatment into HIV care which helps especially to prevent diagnosis 
and treat TB among people with HIV and HIV among TB patients. This has created the chance to additional 
research for better understanding of factors associated with incidence of TB which could help to improve 
service quality. Therefore the outcome of this study provide information about risk factors or the most 
influential covariates that have significant impact on incidence of TB and identify TB incidence rate under 
those significant factors at different time among HIV infected patients during ART care, which can be used 
to design appropriate action to reduce the occurrence of TB among HIV patients. 
 
 
2. METHODS AND MATERIALS 
2.1. Study design and settings 
A six years institution based retrospective follow-up study was conducted in three health facilities 
(Hawassa University referral Hospital, Adare general hospital and millennium health center) which are found 
in Hawassa city, south Ethiopia. The city has 351,656 total populations organized in sub cities; and has one 
public referral hospital, one public general hospital, 10 governmental health centers, 4 private hospitals and 
about 36 private clinics. Hawassa university referral hospital is teaching referral hospital. The HIV care 
service of the hospitals was initiated at 2005 and has three clinics; adult ART, pediatric ART and VCT 
clinics which allowed to offered free ART services. All facilities uses national standardized monitoring and 
evaluation tools, and the data collection and management processes are well controlled and supported by 
electronic data back-up and processing. There were about a total 5,642and 4,410 clients who ever started and 
currently on ART respectively in the three selected facilities. 
 
2.2. Study population and sampling technique  
The Source population were Adults (≥ 15 year) living with HIV who ever registered to chronic HIV 
care and support program in the facilities. All available 554 charts in the three hospitals that enrolled from 
September 1, 2009 to August 31, 2010, were included in the study. Those patients with missing chart or 
incomplete base line and follow up data were excluded. 
 
2.3. Data collection procedures and tools 
All available information on patient records was checked and an appropriate data extraction format 
was prepared in English. Then, data was extracted from patients’ charts by four trained nurses who had 
additional ART training and experience in HIV care. Two data clerk was used to support nurses by 
identifying the charts. Charts were retrieved using the patient’s registration number which was found in data 
base in electronic system. 
 
2.4. Data processing and analysis  
Data was checked for its consistence and completeness; then entered into a computer using EPI info 
version 7 and then exported to the SPSS version 20 for analysis. Data was entered by principal investigator 
and cleaned before analysis. Summary statistics was carried out to describe demographic, baseline and follow 
up data. Incidence Rate (IR) was calculated for entire study period. Life table was used to estimate 
cumulative survival (TB free) of PLWHIV. The Kaplan-Meier curve was used to estimate the median 
duration of TB occurrence. Log rank test was used to compare survival curves between the different 
categories of explanatory variables.  
Both bivariate and multiple cox proportional hazard model were used to identify the predictors. The 
variables with P value < 0.25 in the bivariate analysis were entered to multiple proportional hazard models. 
95% confidence interval of adjusted hazard ratio was computed and variables having p value < 0.05 in 
multiple proportional hazards model was considered as significantly and independently associated with 
dependent variables. The necessary assumption of cox proportional hazard model was checked using 
Schoenfield residual test and graphically. 
 
2.5. Ethical approval 
Ethical clearance was obtained from review board of Arba Minch University College of medicine 
and health science with a reference CMHS/PG/130/08. Letter of permission was obtained from the 
management (CEO) of the hospitals. The head of the HIV care clinics was giving the consent for extracting 
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data from records. Patient names and identification numbers was not extracted so as to ensure confidentiality 
of patient information. 
 
 
3. RESULTS 
Among, 554 patients remaining in the analysis, the mean age was 34.48 +/- 9.14 and almost half, 
267 (48.2%) of them were in the age group 25-34 years. More than half 324(58.5%) of PLHIV were females 
and 337(6.8%) were Orthodox Christian. About 259 (46.8 %) of the participants were married and 207 
(37.4%) have only primary level of education. More than half of then 315(56.7%) were have occupation in 
different level of work status. Majority, 499(90.1%), of the patients came from urban areas. A total of 487 
(87.9%) patients had disclosed their HIV status to either their family, or other relatives. Most of the time they 
disclosed to their wife/husband and brother/sister which accounted 191 (34.5%) and 112(20.2%) 
respectively. Two hundred twenty six (40.8%) of the patients were substance users as shown in Table 1.  
 
 
Table 1. Baseline Socio Demographic Characteristics of PLHIV on Chronic HIV Care at Hawassa City 
Characteristics Number/frequency Percent 
Age   
15-24 45 8.1 
25-34 267 48.2 
35-44 155 28.0 
≥45 87 15.7 
Sex    
Male  230 41.5 
Female  324 58.5 
Marital status    
Single  87 15.7 
Married  259 46.8 
Divorced  125 22.2 
widowed 83 15 
Religion    
Orthodox  337 60.8 
Muslim 39 7 
Protestant 168 30.3 
Catholic 10 1.8 
Level of education    
No education 105 19 
Primary 207 37.4 
Secondary 166 30 
Tertiary 76 13.7 
Occupation    
Yes 313 56.9 
No 231 43.1 
Address   
Urban 499 90.1 
Rural 55 9.9 
Disclosure    
Disclosed 484 87.8 
Not disclosed 67 12.2 
Substance use    
Used 226 41 
Not used 324 59 
Family size   
<2 296 53.8 
3-4 201 36.6 
>5 53 9.6 
 
 
The eligibility criterion for initiation of HAART was mainly CD4 cell count in 316(57%). The 
predominant regiments initially prescribed were a combination of zidovudine, Lamivudine and Nevirapine 
(1c) 197(35.6%) followed by Stavudine, Lamivudine and Efavirenz (1d) (19.9%). One hundred forty (25.6%) 
patients had changed their initial regimen during the follow up period mainly to a combination of Tinofovir, 
Lamivudine and Efavirenz (1e) 85 (15.3%). Only 4(0.7%) patients were switched to second line HAART. 
The predominant reason for changing the initial regimen was drug side effect 117(21.1%) and followed by 
tuberculosis 6(1.1%). Half of the regimen was changed within the first two year of follow up period. About 
three fourth (73.6%) of them were on working functional status at baseline. Two hundred two (36.4%) and 
one hundred eighty eight (33.9%) of the participants were at WHO clinical stage two and three during 
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enrolment respectively. The median CD4 count during enrollment and end of follow up was 203 [IQR:  
117-321] and 525[IQR: 368-696.5] respectively as shown in Table 2. 
 
 
Table 2. Baseline Clinical and Immunological Status of PLHIV 
on Chronic HIV Cares at Hawassa city  
Characteristics Number Percent 
ART eligibility criteria   
CD4 count 314 57 
WHO clinical stage 69 12.5 
Both 168 30.5 
Initial regimen   
1a(30) 100 18.1 
1a(40) 89 16.1 
1b(30) 6 1.1 
1b(40) 43 7.8 
1c 7 1.3 
1d 197 35.6 
1e 110 19.9 
Other 2 0.4 
Regimen change   
Yes 142 25.6 
No 412 74.4 
New regimen   
1b(40) 2 0.4 
1c 3 6 
1d 16 2.9 
1e 85 15.3 
Other 4 0.7 
Reason for change   
Side effect 117 21.1 
Pregnancy 4 0.7 
TB 6 1.1 
Not recorded  4 0.7 
Other 11 2.7 
Past TB history   
Yes 79 14.4 
No 426 77.3 
Not recorded 44 8.3 
Functional status   
Working 405 73.6 
Ambulatory 128 23.1 
Bedridden 16 2.9 
WHO clinical stage   
I 121 21.8 
II 202 36.5 
III 188 33.9 
IV 43 7.8 
CD4 count   
<50 38 6.9 
51-150 140 25.3 
151-250 169 30.5 
251-350 82 14.8 
>350 125 22.6 
 
 
3.1. Tuberculosis incidence density 
Five hundred fifty four study participants were followed for different periods for six years which 
gave us 1830.33 person years of observation. Within the follow up period, 161 new tuberculosis cases were 
observed. Hence, the overall TB incidence density rate (IDR) in the cohort was 8.79 per 100 Person Years. 
Study participants were followed for a minimum of 1 month and a maximum of 72 months. The mean follow 
up period was 39.5 months. Of the incident TB cases, 137(24.7%) were Pulmonary Tuberculosis and 
24(4.3%) were Extra-Pulmonary or/and Disseminated Tuberculosis. One hundred fifteen (71.42%) of the TB 
cases were occurred within the first years of follow up. The highest incidence rate of TB was observed in the 
first year of enrolment (148.71/100 PY) and then decreased in the subsequent years of follow up (19.03 and 
0.8 per 100PY in three and sixth years respectively). Similarly the number of TB incidence among ART 
started patients was decreased crossed the follow up period. This indirectly revealed that reductions in TB 
incidence rate following the stay on HAART. But the highest number of TB incident was observed on the 
newly ART started patients. The cumulative probability of TB survival at the end of one year, two year, three 
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year, four year and six year was 0.79, 0.75, 0.71 and 0.67 respectively. The median survival time from 
enrolment to chronic HIV care to TB occurrence is 60 months (Table 3 and Figure 1).  
 
 
Table 3. Tuberculosis Incidence Density Rate Stratified by Socio-demographic Characteristics 
of PLHIV who were on Chronic HIV Care in Hawassa City 
 Characteristics Total PY of Observation TB TB IDR/100 PY 
Age 15-24 45 160.41 10 6.23 
 25-34 267 872.67 79 9.04 
 35-44 155 532.67 40 7.50 
 ≥45 87 263.58 32 12.14 
Sex Male  230 765.34 67 8.75 
 Female  324 1,065 94 8.82 
Marital status Single  87 267.41 33 12.34 
 Married  259 866.00 74 8.54 
 Divorced  125 388.91 32 8.22 
 Widowed 83 308.00 22 71.42 
Religion Orthodox  337 1070.7 106 9.90 
 Muslim 39 130.08 16 12.30 
 Protestant 168 598.70 37 6.18 
 Catholic 10 32.52 2 6.15 
Level of education No education 105 286.50 34 11.86 
 Primary 207 683.58 65 9.5 
 Secondary 166 574.75 48 8.35 
 Tertiary 76 285.50 14 4.9 
Occupation Yes 313 1064.08 85 7.98 
 No 238 766.25 76 9.91 
Address Urban 499 1653.91 145 8.76 
 Rural 55 176.41 16 9.06 
Disclosure Disclosed 484 1640.08 147 8.96 
 Not disclosed 67 190.25 14 7.35 
Substance use Used* 226 1193.16 83 6.95 
 Not used 325 637.16 78 12.24 
ART eligibility criteria CD4 count 314 1186.16 72 6.07 
 WHO clinical stage 69 221.41 12 5.41 
 Both 168 423.91 77 18.16 
Initial regimen 1a(30) 100 286.33 31 10.82 
 1a(40) 89 32.16 0 0.00 
 1b(30) 8 103.16 23 22.29 
 1b(40) 43 27.91 3 10.74 
 1c 7 707.58 38 5.37 
 1d 197 344.41 34 9.87 
 1e 110 325.41 32 9.83 
Past TB history Yes 79 190.00 46 24.21 
 No 426 1317.82 102 7.74 
 Not recorded 44 167.91 13 7.74 
Functional status Working 405 1531.19 81 5.29 
 Ambulatory 127 279.58 68 24.32 
 Bedridden 16 27.5 12 55.81 
WHO clinical stage I 121 526.84 21 3.98 
 II 202 709.16 47 6.62 
 III 188 524.25 61 11.63 
 IV 43 70.08 32 45.64 
CD4 count <50 38 107.50 18 16.74 
 51-150 140 414.16 55 13.27 
 151-250 169 544.75 48 8.81 
 251-350 82 269.50 15 5.56 
 >350 125 494.41 25 5.05 
Year of follow up ≤1 161 77.33 115 148.71 
 1-3 85 168.08 32 19.03 
 ≥3 311 1586.92 11 0.8 
Enrolment status Pre ART 422 1402.50 135 9.70 
 ART 129 427.83 26 6.07 
*Substance used means those who used at least one of the following alcohol, tobacco or drugs  
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Figure 1.  Kaplan-Meier curve of TB-free survival proportion for PLHIV 
on chronic HIV care at health facilities found in Hawassa city 
 
 
3.2. Predictors of time to TB occurrence  
In the multiple Cox-regression analysis level of education, substance use, past TB history, functional 
status at enrolment, CD4 cell count less than 50, WHO clinical stage IV and enrolment status (being on pre-
ART or on ART) remained statistically significant predictors of TB Occurrence. Accordingly, people living 
with HIV who were ambulatory or bedridden at enrollment were about 3 times higher risk of Developing TB 
at any time as compared to those who were working (AHR=2.89, 95%CI: 1.72-3.78)). Compared with 
patients having tertiary level of education at enrolment, patients with no education 2.6 times tend to have 
higher incidence of TB (AHR= 2.68, 95%CI: 1.41-5.11). Those who were at WHO clinical stage IV had  
more than 3 times higher risk of acquiring TB at any time as compared to those with WHO clinical stage I or 
II (AHR=3.22, 95%CI: 1.91-5.41). Similarly, people living with HIV those who had past TB history were 
about 1.65 time higher risk of TB acquisition as compared to those who do not had (AHR=1.65, 95%CI: 
1.06-2.39). In addition, people living with HIV who were substance use at enrollment were 1.46 times higher 
risk of Developing TB at any time as compared to those who were not addicted (AHR=1.46, 95%CI: 1.03-
2.06). A patient with CD4 cell count less than 50 cell/ul was 2.41 times more likely to have TB at any time 
than a patient with a CD4 cell count greater than 250 cell/ul (AHR=2.41(1.31-4.42). Patients who were on 
pre ART at the enrolment were 1.62 times higher risk of TB acquisition as compared to those who were on 
ART as shown in Table 4. 
 
 
4. DISCUSSION 
The recent increase in worldwide prevalence of HIV infection has contributed to the rising global 
incidence of Tuberculosis [7]. In Ethiopia, infection with TB is a major public health problem with an 
estimated annual incidence of 207 cases per 100,000 populations for all forms of TB. HIV-positive people 
are 26 times at higher risk to develop TB compared to HIV-negative people in countries with a generalized 
HIV epidemic [6]. It is also the most common cause of death among people living with HIV [3].  
In this study of HIV-infected adults who were in HIV chronic care in public health facility of 
Hawassa, we found that the incidence of TB was significantly higher (8.79/100PY). Patients within the first 
year following ART initiation had a temporary increased risk. Illiteracy, Past TB history, lower CD4 cell 
count, advanced WHO stage IV and enrolment status (being on pre ART) were associated with a higher risk 
of developing active TB. Accordingly, the overall incidence of TB was 8.79 per 100 Person-Years. It was 
similar with study conducted in Gonder [9], Ethiopia (7.88 per 100PY) because they use the same protocol 
with our study area and have the same socio-economic characteristics. But our finding was higher from study 
conducted in Nigeria (2.58/100PY) and Mozambique (2.32/100PY). This is because of methodological 
difference; they excluded patients on pre ART and the first three months after initiation of ART to minimize 
the effect of IRIS. Analysis that includes pre ART and the first 3 months after initiation of ART reported the 
highest TB incidence, as in our case [10]. 
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The highest incidence rate of TB was observed in the first year of enrolment. TB incidence may rise 
during the initial months on ART (as in our case), which is largely due to ART-induced unmasking of 
subclinical active TB and delayed diagnosed of unspecific symptomatic patients in resource-limited settings. 
However, TB incidence declined with duration increment on ART, which likely reflects the concurrent CD4+ 
cell count increase and immune reconstitution due to ART. Because ART suppresses viral activity and 
promotes the restoration of the immune system, hence leading to a reduced risk of re-activating latent TB or 
of emerging opportunistic infections [10]-[18]. The result also showed that almost all of patients were started 
ART with in the first year of follow up which is responsible for IRIS. The other reason might be about 41.7 
% of study participant enrolled to HIV chronic care service at their advanced WHO clinical stage (III &IV). 
 
 
Table 4. Multiple Cox Regression Analysis of Predictors of Tuberculosis among PLHIV Cohorts 
on Chronic HIV Care at Health Facility Found in Hawassa  
variables 
Survival status 
CHR(95%CI) AHR(95%CI) 
Level of education   
No educ. 1.34(0.99-1.80) 2.68(1.41-5.11) 
Primary 1.12(0.88-1.45) 1.19(0.65-2.16) 
Secondary 1.05(0.50-1.21) 1.5(0.81-2.78) 
Tertiary 1 1 
Substance use    
Used* 1.56(1.14,2.12) 1.46(1.03-2.06) 
Not used 1 1 
Past TB history   
Yes 2.45(1.32,4.53) 1.65(1.06-2.39) 
No/not recorded 1 1 
Functional status   
Working 1 1 
Ambulatory/Bedridden 3.91(2.86,5.34) 2.89(1.72-3.78) 
WHO clinical stage   
I /II 1 1 
III 1.30(1.33,2.66) 1.17(0.79,1.75) 
IV 6.26(4.10,9.57) 3.22(1.91-5.41) 
CD4 count   
<50 3.05(1.78,5.33) 2.41(1.31-4.42) 
51-250 1.87(1.29,2.69) 1.23(0.82,1.85) 
≥251 1 1 
Enrolment status   
Pre ART 1.51(0.99-2.30) 1.62(1.03-2.54) 
ART 1 1 
*Substance used means those who used at least one of the following alcohol, tobacco or drugs 
 
 
In the analysis, predictors that were significantly associated with increased risk of TB were past TB 
history, addiction, ambulatory or bedridden functional status WHO clinical stage IV and low CD4 cell count 
at baseline. All these predictors had already been identified in previous studies [13]-[15], [18]-[23]. In this 
study we found that the TB incidence was higher in patients with ambulatory or bedridden baseline 
functional status as compared to working functional status. This is in line with study conducted in Gonder 
(AHR=1.64, 95%CI: 1.13-2.38). This could be due to the fact that patients became bed reddened or 
ambulatory as result of affected by many infectious diseases when their CD4 cell count is low and as a result 
immunity became compromised the patients were eligible OIs including TB [9]. 
Illiteracy from the socio-demographic factors remained in the final model, by predicting the risk of 
developing TB. This finding was in line with study conducted in Brazil (AHR=1.95, 95%CI: 1.29–2.94). 
Poverty and illiteracy were closely associated; as a result those who were illiterate were expected to live 
unhygienic condition, unbalanced nutrition and lack of information or awareness (14, 24). WHO clinical 
stage IV had 3 times (AHR=2.93, 95%CI=1.72-4.98) higher risk of TB incidence than WHO clinical stage I 
or II, this is in line with study done in Gonder (AHR=3.82, 95%CI: 1.86-7.85)) at Dare Salam, Tanzania 
3.44(3.06–3.87) [18]. Another prospective study results which was also conducted in Tanzania shows similar 
(AHR=2.48, 95%CI: 1.88–3.26) there were many studies which was concurrent with our study [9]-[11], [15]-
[18]. Even though, TB can occur at any WHO clinical stage it is more common in advanced clinical stage [8]. 
Baseline CD4 cell count of <50 cells/ µl was a very strong and independent risk factor associated 
with a higher risk of TB in patients enrolled to chronic HIV care (AHR=2.41 , 95% CI=1.31-4.42). In fact, 
the highest TB incidence (16.74 /100PY) in this cohort analysis was observed among patients with baseline 
CD4 count <50 cells/µl. Lower baseline CD4 count before initiation of ART has consistently been indicated 
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as an independent risk factor for occurrence of Tuberculosis during the course of HIV treatment and care in 
different settings [9],[13],[18],[22]. A study in West Africa has indicated that baseline CD4 count has no any 
association with the occurrence of TB during HAART [24]-[25]. This was because the study had limitations 
in design related to size of the study population, the number of TB cases, diagnostic criteria for tuberculosis 
and restricted cohort composition. 
According to our results, high risk behaviors like substance use; to alcohol, tobacco or drugs were 
1.46 times higher risk of developing TB than not used. These also identified as risk factors among non HIV 
positive peoples. These high risk behaviors might predispose HIV patients to TB infection factors [21]. 
According to our results, past TB history of infection was identified as risk factors. This might be because 
activation of latent TB on people who were immune compromised as a result of HIV infection than those 
who did not had history of TB infection [14], [21]. 
Since it was based on secondary data some of the important predicators which had a significant  
association with TB occurrence with other studies like body mass index were not included in the analysis due 
to incomplete registration of height in almost half of the charts and as well as Heamoglobin level. It is also 
difficult to know the exact date of tuberculosis occurrence as it is a chronic disease and not recorded the 
exact date of diagnosis which may over-estimate the median time of tuberculosis. Missing is another concern.  
 
 
5. CONCLUSION   
The burden of TB among pre ART enrollees was significant. Most of the cases (TB) were occurred 
in the first year of enrolment to chronic HIV care. Advanced  WHO clinical stage (stage IV), limited  
functional status, past TB history, substance use, being on pre ART and low CD4 (<50cell/ul) count at 
enrollment were found to be the independent predictor of tuberculosis occurrence. Strengthen the importance 
of TB screening and early initiation of ART is very important to limit the time spent at low level of CD4 
count regardless their CD4 count and WHO clinical.  
 
 
ABBREVIATIONS 
AHR: Adjusted hazard ratio, ART: Anti-retroviral therapy, HAART: highly active antiretroviral therapy, 
IDR: incidence density rate, OI: opportunistic infection, PLWHA: people living with HIV/AIDS, TB: 
Tuberculosis, VCT: voluntary counseling and testing, WHO: world health organization. 
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